Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - AUXILIUM PHARMACEUTICALS INC | a13-6014_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 26, 2013
Auxilium Pharmaceuticals, Inc.
(Exact Name of Registrant Specified in Charter)
Delaware |
|
000-50855 |
|
23-3016883 |
(State or Other |
|
(Commission File |
|
(I.R.S. Employer |
Jurisdiction of |
|
Number) |
|
Identification No.) |
Incorporation) |
|
|
|
|
640 Lee Road |
|
|
Chesterbrook, PA |
|
19087 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (484) 321-5900
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On February 26, 2013, Auxilium Pharmaceuticals, Inc. (the Company) issued a press release announcing its results of operations for the fiscal quarter/year ended December 31, 2012. The full text of such press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 7.01 Regulation FD Disclosures.
As previously announced, the Company will conduct a conference call today, Tuesday, February 26, 2013 at 10:00 a.m. ET to discuss fourth quarter and full year results. The presentation slides to be used during the call will be available on the For Investors section of the Companys web site (http://www.auxilium.com) under the Presentations tab beginning at 10:00 a.m. ET on Tuesday, February 26, 2013. A question and answer session will follow the presentation. The conference call and the presentation slides will be simultaneously web cast on the For Investors section of the Auxilium web site under the Events tab beginning at 10:00 a.m. ET on Tuesday, February 26, 2013, and will remain available for future review until May 26, 2013. The information contained in, or that can be accessed through the Companys web site, is not a part of this filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
The following press release is furnished as an exhibit to this Current Report on Form 8-K pursuant to Item 2.02 and shall not be deemed to be filed:
99.1 Press Release dated February 26, 2013 issued by Auxilium Pharmaceuticals, Inc.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AUXILIUM PHARMACEUTICALS, INC. | |
|
|
|
|
|
|
Date: February 26, 2013 |
By: |
/s/ James E. Fickenscher |
|
|
James E. Fickenscher |
|
|
Chief Financial Officer |